Skip to content Skip to navigation

Understanding clinical adoption: How a therapy is reimbursed.

Understanding clinical adoption: How a therapy is reimbursed.

A presentation by Nancy Sikich, MSc (Health Quality Ontario) at the Bench to Bedside for Biotherapeutics (B3) Workshop held in Toronto on October 5, 2017.

In this seminar, Nancy Sikich discusses the role of Health Quality Ontario (HQO) in assessing and implementing innovations within a healthcare framework. Through a series of examples, this seminar covers how health technologies are assessed, evaluated for adoption and the reimbursement pathway of new technologies.

This video was posted by the Ontario Institute for Regenerative Medicine, in partnership with BioCanRx, CCRM, CellCAN, Foundation Fighting Blindness, Ontario Institute for Cancer Research and Stem Cell Network.